Inventor · disambiguated record
David P. Hesson
Also filed as: HESSON DAVID · HESSON DAVID P · HESSON DAVID PAUL
10 granted patents·17 pending applications·133 citations·filing 1985–2024
88Inventor score
Files withCLEAR CREEK BIO INC15NEURON THERAPEUTICS INC3DU PONT2INTEGRA LIFESCIENCES CORP2DU PONT MERCK PHARMA1
Top patents by PatentIndex Score
27 records- 0193US4680299A2-phenyl-4-quinolinecarboxylic acids and pharmaceutical compositions thereofDU PONT·Filed 1985·Granted Jul 14, 1987·57 cites·22 claims
- 0288US11230528B2Compositions and methods for inhibiting dihydroorotate dehydrogenaseCLEAR CREEK BIO INC·Filed 2020·Granted Jan 25, 2022·2 cites·20 claims
- 0388US8497243B2Methods and compositions useful in the treatment of mucositisHESSON DAVID PAUL·Filed 2008·Granted Jul 30, 2013·12 cites·24 claims
- 0485US4639454APhenylquinazolinecarboxylic acids and derivatives as cancer chemotherapeutic agentsDU PONT·Filed 1985·Granted Jan 27, 1987·23 cites·21 claims
- 0584US6689756B2Treatment of neurological diseaseINTEGRA LIFESCIENCES CORP·Filed 2002·Granted Feb 10, 2004·28 cites·3 claims
- 0681US10889548B2Compositions and methods for inhibiting dihydroorotate dehydrogenaseCLEAR CREEK BIO INC·Filed 2019·Granted Jan 12, 2021·2 cites·6 claims
- 0779US12076315B2Stable polymorphic compositions of brequinar sodium and methods of use and manufacture thereofCLEAR CREEK BIO INC·Filed 2021·Granted Sep 3, 2024·1 cites·14 claims
- 0871US12012383B2Compositions and methods for inhibiting dihydroorotate dehydrogenaseCLEAR CREEK BIO INC·Filed 2021·Granted Jun 18, 2024·0 cites·19 claims
- 0969US2025248989A1Stable polymorphic compositions of brequinar sodium and methods of use and manufacture thereofCLEAR CREEK BIO INC·Filed 2024·Application pending·0 cites
- 1066US2021154186A1Compositions and methods for inhibiting dihydroorotate dehydrogenaseCLEAR CREEK BIO INC·Filed 2021·Application pending·0 cites
- 1161US9884899B2Methods for treating fibrosis using CRP antagonistsLUPHER JR MARK L·Filed 2008·Granted Feb 6, 2018·2 cites·10 claims
- 1261US5032597AMethod of using phenylquinolinecarboxylic acids and derivatives for lymthoid leukemia treatment in a mammalDU PONT MERCK PHARMA·Filed 1987·Granted Jul 16, 1991·6 cites·11 claims
- 1361US2019290634A1Compositions and methods for inhibiting dihydroorotate dehydrogenaseCLEAR CREEK BIO INC·Filed 2019·Application pending·0 cites
- 1453US2022105120A1Compositions and methods for inhibiting inosine monophosphate dehydrogenaseCLEAR CREEK BIO INC·Filed 2020·Application pending·0 cites
- 1551US2021113548A1Methods for determining a drug dosing regimenCLEAR CREEK BIO INC·Filed 2020·Application pending·0 cites
- 1650US2022218731A1Combination therapies for cancer treatmentCLEAR CREEK BIO INC·Filed 2020·Application pending·0 cites
- 1750US2021115493A1Methods for determining a drug dosing regimenCLEAR CREEK BIO INC·Filed 2020·Application pending·0 cites
- 1850US2022202803A1Combination therapies including inhibitors of dihydroorotate dehydrogenaseCLEAR CREEK BIO INC·Filed 2020·Application pending·0 cites
- 1947US2019290892A1Methods of determining dosing of a therapeutic agent based on measured levels of a metaboliteCLEAR CREEK BIO INC·Filed 2019·Application pending·0 cites
- 2047US2022105121A1Compositions and methods for inhibiting inosine monophosphate dehydrogenaseCLEAR CREEK BIO INC·Filed 2020·Application pending·0 cites
- 2147US2019290635A1Methods of treating brain cancer using agents that alter activity of a metabolic pathwayCLEAR CREEK BIO INC·Filed 2019·Application pending·0 cites
- 2242US2003060421A1Kits and compositions supporting intracranial perfusionsNEURON THERAPEUTICS INC·Filed 2001·Application pending·0 cites
- 2341US2003135196A1Treatment of neurologic hemorrhageNEURON THERAPEUTICS INC·Filed 2002·Application pending·0 cites
- 2439US2002193335A1Gene therapy for neurological tissuesFiled 2002·Application pending·0 cites
- 2538US2006184098A1Subarachnoid spinal catheter for transporting cerebrospinal fluidINTEGRA LIFESCIENCES CORP·Filed 2003·Application pending·0 cites
- 2636US2003163181A1Protection of neurological tissue by direct CNS perfusion coolingNEURON THERAPEUTICS INC·Filed 2002·Application pending·0 cites
- 2731US2002193285A1Neuroprotectants formulations and methodsFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David P. Hesson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →